Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
Status:
Terminated
Trial end date:
2019-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the feasibility of intranasal ketamine for adequate
sedation of children undergoing minor procedures in the Emergency Department. An intranasal
dose of 10mg/kg will be used in patients requiring procedural sedation. The investigators
hypothesize that this dose of intranasal ketamine will be able to provide adequate sedation
and analgesia for the physician to successfully complete the planned diagnostic or
therapeutic intervention (Pediatr Emer Care 2012;28: 767-70). The primary endpoint will be
successful sedation, as defined by the ability to complete the planned procedure without
rescue medication, which includes re-dosing of the same medication.